drugset / Trial / NCT02367885
Phase 1/2 Study of TAK-850 Intramuscular Injection in Healthy Pediatric Participants
Non-randomizedSingle-groupOpen-labelPrevention
Summary
The purpose of this study is to evaluate the safety and immunogenicity of an intramuscular injection of TAK-850 in healthy pediatric Japanese participants.
Timeline
- Start
- 2015-02
- Primary completion
- 2015-05
- Completion
- 2015-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TAK-850 | Vaccine | 0.25 ml | Intramuscular |
| Subject | TAK-850 | Vaccine | 0.5 ml | Intramuscular |